Item 5.07 Submission of Matters to a Vote of Security Holders

The 2022 Annual Meeting of Stockholders (the "Annual Meeting") of Inhibrx, Inc. (the "Company") was held on May 25, 2022 at 12:00 p.m. Pacific Time online in a virtual format. Of the Company's 39,026,469 shares of common stock issued and outstanding and eligible to vote as of the record date of March 28, 2022, a quorum of 36,005,321 shares, or approximately 92% of the eligible shares, was present virtually or represented by proxy. Each of the matters set forth below is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 13, 2022. The following actions were taken at the Annual Meeting:

Proposal 1

Election of the following nominees as Class II Directors of the Company, to serve until the 2025 Annual Meeting and until their successors are duly elected and qualified.


                      Votes For    Votes Withheld     Broker Non-Votes

Douglas G. Forsyth 18,612,366 10,953,127 6,439,828 Kimberly Manhard 20,144,636 9,420,857 6,439,828





Proposal 2

Ratification of the selection of BDO USA, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022.



 Votes For     Votes Against    Votes Abstained    Broker Non-Votes
 35,872,422          -              132,899               -



Proposal 3

Selection of the frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.



   1 Year      2 Years     3 Years     Abstain     Broker Non-Votes
 29,559,505      815        3,548       1,625         6,439,828

The Company has determined an annual frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.

© Edgar Online, source Glimpses